04 Oct, EOD - Indian

SENSEX 81688.45 (-0.98)

Nifty 50 25014.6 (-0.93)

Nifty Bank 51462.05 (-0.74)

Nifty IT 41912.5 (0.36)

Nifty Midcap 100 58474.45 (-0.93)

Nifty Next 50 74620.25 (-1.10)

Nifty Pharma 23094.7 (-0.36)

Nifty Smallcap 100 18758.65 (-1.02)

04 Oct, EOD - Global

NIKKEI 225 38635.62 (0.22)

HANG SENG 22736.87 (2.82)

S&P 5807.5 (0.80)

Login/Signup
LOGIN HERE
Cancel

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
04-Sep-2024 07-Sep-2024 Others Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/09/2024 inter alia to consider and approve 1. To consider and approve the Draft Notice for calling 17th Annual General Meeting 2. To Approve the Draft of Directors Report 3. To Recommendation a final dividend @ 3.3% (i.e Rs. 0.33/-) per equity share of Rs. 10/- 4. To consider and approve the increase in the Authorized Share Capital of the Company 5. To consider and approve a change in terms of payment of remuneration to Mr. Mustaqim Nisarahmed Sabugar Managing Director (Din: 01456841) of the company 6. To consider and approve a change in terms of payment of remuneration of Mr. Shakil Nisarahmed Sabugar Whole-Time Director (Din: 01474868) of the company Board in its meeting dated 07th September, 2024 approved final dividend at the rate of 3.30% subject to approval of Member at 17th AGM (As Per BSE Announcement dated on 07.09.2024)
08-Aug-2024 08-Aug-2024 Change in Auditors Resignation And Appointment of Internal Auditor
17-May-2024 24-May-2024 Accounts Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve To consider approve and take on record the Audited Financial Results for the half year ended and year ended on March 31 2024 as per Regulation 33 of the SEBI (LODR) Regulation 2015 Reappointment of Secretarial Auditor M/S Murtuza Mandorwala & Associates for the financial year 2024-2025 Approval of Audited Financial Result for Half year and Financial year ended on 31st March, 2024 (As Per BSE Announcement dated on 24.05.2024) Reappointment of Internal Auditor M/S Altaf Sachora & Co for the financial year 2024-2025 (As Per BSE Announcement Dated on 25/05/2024)
02-Nov-2023 10-Nov-2023 Half Yearly Results Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1. To consider approve and take on record the Unaudited Standalone Financial Result of the Company for the Half Year Ended on 30th September 2023 as per Regulation 33 of the SEBI (LODR) Regulation 2015; 2. Such Other agendas as may be considered necessary with the permission of the chair. This is to inform you that, the Board of Directors at their meeting held on today i.e. 10th November, 2023 at 02:30 P.M. at Shelter Nagar, Nr. S. T. Bus Stand, Himmatnagar GJ 383001 IN, interalia considered and approved the following matter: 1. Approval of Standalone Unaudited Financial Result for the Half Year ended on 30th September, 2023 as per Regulation 33 of the SEBI (LODR) Regulations, 2015 along with Limited Review report; 2. Appointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretary, as Secretarial Auditor of the Company for the Year 2023-24; 3. Appointment of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W, Ahmedabad , as Internal Auditors of the Company to conduct the Internal Audit for the financial year 2023-24. The Board Meeting started at 02:30 P.M. and ended on 03:15 P.M. Submission of Half Yearly result as on 30th September, 2023 Appointment of Secretarial Auditor for Financial Year 2023-2024 Appointment of Internal Auditor For Financial year 2023-2024 (As Per BSE Announcement Dated on 10.11.2023)